Autor/in Bauer, L 1 Decker, T Furlanetto, J 1 Hoffmann, O 1 Link, T 1 Lübbe, K 1 Mundhenke, C 1 Müller, V 1 Reinisch, M 1 Schmidt, M 1 Thill, M 1 alle zeigenListe einklappen
A multicentre, randomised, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (DESIREE) Schmidt, M Lübbe, K Decker, T Thill, M Bauer, L Müller, V Link, T 2022 - Forschungsinformationssystem des UKE - frei zugänglich
